Next, differential abundance analysis indicated that only CD8+ SELENOK+ T cells were increased in stage IV CRC compared with stage I CRC, suggesting insignificant alteration of the proportion of CD8+ T cells in TME during CRC progression (Figure 5C). Here, CD8A is linked to colorectal carcinoma.